These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 11708476)

  • 1. Detection of amplifiable messenger RNA in the serum of patients with lung cancer.
    Fleischhacker M; Beinert T; Ermitsch M; Seferi D; Possinger K; Engelmann C; Jandrig B
    Ann N Y Acad Sci; 2001 Sep; 945():179-88. PubMed ID: 11708476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment of a new method, transcription-reverse transcription concerted reaction, for detection of plasma hnRNP B1 mRNA, a biomarker of lung cancer.
    Sato A; Sueoka-Aragane N; Saitoh J; Komiya K; Hisatomi T; Tomimasu R; Hayashi S; Sueoka E
    J Cancer Res Clin Oncol; 2008 Nov; 134(11):1191-7. PubMed ID: 18461365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative quantification of plasma hnRNP B1 mRNA in non-small cell lung cancer patients by real-time PCR].
    Kim JM; Hwang SH; Song EJ; Lee SY; Kim YD; Lee CH; Lee MK; Chang CL; Lee EY
    Korean J Lab Med; 2009 Jun; 29(3):249-55. PubMed ID: 19571624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of plasma hnRNP B1 mRNA, a new cancer biomarker, in lung cancer patients by quantitative real-time polymerase chain reaction.
    Sueoka E; Sueoka N; Iwanaga K; Sato A; Suga K; Hayashi S; Nagasawa K; Nakachi K
    Lung Cancer; 2005 Apr; 48(1):77-83. PubMed ID: 15777973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of heterogeneous nuclear ribonucleoprotein A2/B1 protein in the pathogenesis of non-small cell lung cancer].
    Shi Y; Chen Y; Hou YY; Ji CH; Hu Q; Zhou Y; Su JA; Tan YS
    Zhonghua Zhong Liu Za Zhi; 2011 Feb; 33(2):110-4. PubMed ID: 21575478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating RNA as a tumor marker: detection of 5T4 mRNA in breast and lung cancer patient serum.
    Kopreski MS; Benko FA; Gocke CD
    Ann N Y Acad Sci; 2001 Sep; 945():172-8. PubMed ID: 11708475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined detection of CEA, CK-19 and c-met mRNAs in peripheral blood: a highly sensitive panel for potential molecular diagnosis of non-small cell lung cancer.
    Sheu CC; Chang MY; Chang HC; Tsai JR; Lin SR; Chang SJ; Hwang JJ; Huang MS; Chong IW
    Oncology; 2006; 70(3):203-11. PubMed ID: 16809939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of tumor-specific mRNA in cell-free bronchial lavage supernatant in patients with lung cancer.
    Engel E; Schmidt B; Carstensen T; Weickmann S; Jandrig B; Witt C; Fleischhacker M
    Ann N Y Acad Sci; 2004 Jun; 1022():140-6. PubMed ID: 15251953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum microRNA-365 in combination with its target gene TTF-1 as a non-invasive prognostic marker for non-small cell lung cancer.
    Liu Y; Zhang G; Li H; Han L; Fu A; Zhang N; Zheng Y
    Biomed Pharmacother; 2015 Oct; 75():185-90. PubMed ID: 26337230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermal growth factor receptor mRNA in peripheral blood of patients with pancreatic, lung, and colon carcinomas detected by RT-PCR.
    Clarke LE; Leitzel K; Smith J; Ali SM; Lipton A
    Int J Oncol; 2003 Feb; 22(2):425-30. PubMed ID: 12527944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneous nuclear ribonucleoprotein B1 as a new marker of early detection for human lung cancers.
    Sueoka E; Goto Y; Sueoka N; Kai Y; Kozu T; Fujiki H
    Cancer Res; 1999 Apr; 59(7):1404-7. PubMed ID: 10197602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiplex PCR-based detection of circulating tumor cells in lung cancer patients using CK19, PTHrP, and LUNX specific primers.
    Katseli A; Maragos H; Nezos A; Syrigos K; Koutsilieris M
    Clin Lung Cancer; 2013 Sep; 14(5):513-20. PubMed ID: 23810363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitive detection of small cell lung carcinoma cells by reverse transcriptase-polymerase chain reaction for prepro-gastrin-releasing peptide mRNA.
    Saito T; Kobayashi M; Harada R; Uemura Y; Taguchi H
    Cancer; 2003 May; 97(10):2504-11. PubMed ID: 12733150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low specificity of cytokeratin 19 reverse transcriptase-polymerase chain reaction analyses for detection of hematogenous lung cancer dissemination.
    Krismann M; Todt B; Schröder J; Gareis D; Müller KM; Seeber S; Schütte J
    J Clin Oncol; 1995 Nov; 13(11):2769-75. PubMed ID: 7595737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of tumor-associated circulating mRNA in serum, plasma and blood cells from patients with disseminated malignant melanoma.
    Hasselmann DO; Rappl G; Rössler M; Ugurel S; Tilgen W; Reinhold U
    Oncol Rep; 2001; 8(1):115-8. PubMed ID: 11115581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic and diagnostic relevance of hnRNP A2/B1, hnRNP B1 and S100 A2 in non-small cell lung cancer.
    Zech VF; Dlaska M; Tzankov A; Hilbe W
    Cancer Detect Prev; 2006; 30(5):395-402. PubMed ID: 17067748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular detection and prognostic value of circulating cytokeratin-19 messenger RNA-positive and HER2 messenger RNA-positive cells in the peripheral blood of women with early-stage breast cancer.
    Ignatiadis M; Perraki M; Apostolaki S; Politaki E; Xenidis N; Kafousi M; Stathopoulos E; Lianidou E; Sotiriou C; Georgoulias V; Mavroudis D
    Clin Breast Cancer; 2007 Dec; 7(11):883-9. PubMed ID: 18269779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of progastrin-releasing peptide and gastrin-releasing peptide receptor mRNA transcripts in tumor cells of patients with small cell lung cancer.
    Uchida K; Kojima A; Morokawa N; Tanabe O; Anzai C; Kawakami M; Eto Y; Yoshimura K
    J Cancer Res Clin Oncol; 2002 Dec; 128(12):633-40. PubMed ID: 12474049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.
    Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J
    Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung cancer prevention with (-)-epigallocatechin gallate using monitoring by heterogeneous nuclear ribonucleoprotein B1.
    Fujimoto N; Sueoka N; Sueoka E; Okabe S; Suganuma M; Harada M; Fujiki H
    Int J Oncol; 2002 Jun; 20(6):1233-9. PubMed ID: 12012004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.